First drug for hepatitis D has been approved by european commission

(German Center for Infection Research) The European Commission has approved Hepcludex for the treatment of chronic hepatitis D infection / Successful translation of basic research into clinical applications / entry blocker also demonstrates effectiveness against hepatitis B